| Size | 1 Plate Kit, 2 Plate Kit, 5 Plate Kit |
| Estimated Lead Time | 1-2 business days |
| Species | Human, Mouse, Rat |
| Sensitivity | 2.544 ng/ml |
| Compatible Sample Types | Plasma, Serum, Urine |
| Quantitative/Semi-Quantitative | Quantitative |
| Solid Support | 96-well Microplate |
| Design Principle | Competition-based |
| Method Of Detection | Colorimetric |
| Research Area | Cancer, Alzheimer's Disease, Methylation, Epigenetics, RNA/DNA Modification |
| Shipping Type | Blue ice |
| Storage | 2-8°C |
RNA modifications affect RNA metabolism and are involved in many different biological processes. Mono-methylation of adenosine in the N1 position, N1-methyladensoine (m1A), is a reversible modification that was first discovered in tRNA in 1966. Decades later, m1A was found in tRNA, rRNA, mitochondrial RNA and mRNA. It has been verified that m1A dysregulation affects multiple cellular processes, including RNA structural stability, folding, interactions with proteins, cell viability, impaired self-renewal ability, cell proliferation, and cell death. They tend to be conserved and have been implicated in many critical biological processes including development, disease, circadian rhythm and embryonic stem cell fate transition, as well as age-related disorders such as Alzheimer’s disease.
Today, it is recognized that the dynamic regulation of m1A in response to physiological stress and the dysregulated expression of m1A regulators are correlated with tumorigenesis and cancer recurrence. Urine samples of various cancers, rheumatoid arthritis, and AIDS patients have all demonstrated high levels of m1A, which supports its role as a functional detection biomarker. The urinary m1A correlates with m1A level in tissue from the same patients with esophageal cancer. Furthermore, elevated serum levels of m1A have been detected under stress conditions. Recent m1A research is uncovering new roles and mechanisms involving m1A. However, the complete role of 1-methyladenosine as a modified nucleoside has yet to be elucidated.
The RayBio® m1A ELISA Kit is a competitive enzyme immunoassay developed for rapid detection and quantitation of m1A in urine, serum, or plasma samples collected from human, rat or mouse. The quantity of m1A is determined by a known m1A standard curve. The m1A kit has a high sensitivity of approximately 2.544 ng/ml. The performance was also verified to exhibit good characteristics in terms of linearity, stability, precision, and spiking & recovery. Each kit provides sufficient reagents to perform up to 96 assays, including standard curve and unknown samples.
| Component | Size / Description |
|---|---|
| Microplate | A 96-well (12 strips x 8 wells) plate |
| Wash Buffer (20X) | 25 mL |
| Standard m1A | 2 vials |
| Anti-m1A Antibody | 10 µL |
| Assay Diluent B | 15 mL |
| Positive Control | 2 vials |
| HRP-conjugated secondary antibody | 5 µL |
| TMB One-Step Substrate Reagent | 12 mL |
| Stop Solution | 12 mL |
The entire kit may be stored at -20°C to -80°C for up to 1 year from the date of shipment. For extended storage, it is recommended to store it at -80°C. Avoid repeated freeze-thaw cycles.
Your cart is empty.
m1A (N1-methyladenosine) ELISA Kit
m1A (N1-methyladenosine) ELISA Kit